688626 翔宇医疗
已收盘 02-27 15:00:01
资讯
新帖
简况
每周股票复盘:翔宇医疗(688626)2025年净利降23.55%
证券之星 · 50分钟前
每周股票复盘:翔宇医疗(688626)2025年净利降23.55%
翔宇医疗(688626)披露2025年度业绩快报公告,2月27日股价上涨2.7%
证券之星 · 02-27 22:44
翔宇医疗(688626)披露2025年度业绩快报公告,2月27日股价上涨2.7%
翔宇医疗:“面向难治性抑郁症的闭环经颅刺激系统”项目入围2025年人工智能医疗器械创新任务揭榜挂帅名单
证券日报 · 01-15
翔宇医疗:“面向难治性抑郁症的闭环经颅刺激系统”项目入围2025年人工智能医疗器械创新任务揭榜挂帅名单
【机构调研记录】中邮基金调研翔宇医疗
证券之星 · 01-15
【机构调研记录】中邮基金调研翔宇医疗
【私募调研记录】瑞民投资调研新开普、翔宇医疗
证券之星 · 01-15
【私募调研记录】瑞民投资调研新开普、翔宇医疗
【私募调研记录】景泰利丰调研翔宇医疗
证券之星 · 01-15
【私募调研记录】景泰利丰调研翔宇医疗
【私募调研记录】明世伙伴基金调研翔宇医疗
证券之星 · 01-15
【私募调研记录】明世伙伴基金调研翔宇医疗
【私募调研记录】正圆投资调研翔宇医疗
证券之星 · 01-15
【私募调研记录】正圆投资调研翔宇医疗
股市必读:翔宇医疗(688626)1月14日披露最新机构调研信息
证券之星 · 01-15
股市必读:翔宇医疗(688626)1月14日披露最新机构调研信息
翔宇医疗最新公告:股东安阳启旭拟减持不超3%股份
证券之星 · 01-13
翔宇医疗最新公告:股东安阳启旭拟减持不超3%股份
每周股票复盘:翔宇医疗(688626)因股价涨幅登龙虎榜
证券之星 · 01-11
每周股票复盘:翔宇医疗(688626)因股价涨幅登龙虎榜
马斯克放话“将量产”引爆脑机接口行情,多家上市公司紧急提示风险,是题材炒作还是新风口?
每日经济新闻 · 01-07
马斯克放话“将量产”引爆脑机接口行情,多家上市公司紧急提示风险,是题材炒作还是新风口?
股市必读:翔宇医疗(688626)登1月6日交易所龙虎榜
证券之星 · 01-07
股市必读:翔宇医疗(688626)登1月6日交易所龙虎榜
2连板翔宇医疗:目前主要聚焦非侵入式脑机接口技术截至2025年末尚未实现规模化销售
证券之星 · 01-06
2连板翔宇医疗:目前主要聚焦非侵入式脑机接口技术截至2025年末尚未实现规模化销售
异动快报:翔宇医疗(688626)1月6日9点34分触及涨停板
中金财经 · 01-06
异动快报:翔宇医疗(688626)1月6日9点34分触及涨停板
马斯克放出“量产时间表”,脑机接口集体涨停,商业化拐点来了?
华尔街见闻 · 01-05
马斯克放出“量产时间表”,脑机接口集体涨停,商业化拐点来了?
异动快报:翔宇医疗(688626)1月5日9点34分触及涨停板
证券之星 · 01-05
异动快报:翔宇医疗(688626)1月5日9点34分触及涨停板
翔宇医疗(688626)披露为全资子公司提供担保的进展公告,12月10日股价下跌1.17%
证券之星 · 2025-12-10
翔宇医疗(688626)披露为全资子公司提供担保的进展公告,12月10日股价下跌1.17%
翔宇医疗:公司不存在逾期担保情况
证券日报 · 2025-12-10
翔宇医疗:公司不存在逾期担保情况
翔宇医疗(688626)公司公告取消监事会并修订公司章程,11月24日股价上涨1.87%
证券之星 · 2025-11-24
翔宇医疗(688626)公司公告取消监事会并修订公司章程,11月24日股价上涨1.87%
加载更多
公司概况
公司名称:
河南翔宇医疗设备股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-03-31
主营业务:
河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。公司是同行业率先通过ISO9001和YY/T0287idtISO13485医疗器械质量管理体系、ISO14001环境管理体系、OHSAS18001职业健康安全管理体系和知识产权管理五个体系认证的企业。报告期末,公司已获得专利1,933项,参与起草或参与评定36个国家行业标准,获得省级科技成果248项。
发行价格:
28.82
{"stockData":{"symbol":"688626","market":"SH","secType":"STK","nameCN":"翔宇医疗","latestPrice":67.37,"timestamp":1772175601000,"preClose":65.6,"halted":0,"volume":2694965,"delay":0,"changeRate":0.027,"floatShares":160000000,"shares":160000000,"eps":0.4595,"marketStatus":"已收盘","change":1.77,"latestTime":"02-27 15:00:01","open":65.01,"high":67.83,"low":64.9,"amount":180000000,"amplitude":0.0447,"askPrice":67.38,"askSize":43,"bidPrice":67.37,"bidSize":89,"shortable":0,"etf":0,"ttmEps":0.4595,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":5,"adr":0,"adjPreClose":65.6,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":72.16,"lowLimit":59.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"isCdr":false,"pbRate":5.32,"roa":"--","peRate":146.615887,"roe":"2.09%","epsLYR":0.66,"committee":0.328302,"marketValue":10779000000,"turnoverRate":0.0168,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-03-02。","afterMarket":{"amount":0,"volume":0,"close":67.37,"buyVolume":200,"sellVolume":0,"time":1772177637558,"indexStatus":"已收盘 02-27 15:30:00","preClose":65.6},"floatMarketCap":10779000000},"requestUrl":"/m/hq/s/688626","defaultTab":"news","newsList":[{"id":"2616843166","title":"每周股票复盘:翔宇医疗(688626)2025年净利降23.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843166","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843166?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:04","pubTimestamp":1772301853,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,翔宇医疗报收于67.37元,较上周的68.28元下跌1.33%。本周,翔宇医疗2月24日盘中最高价报68.88元。本周关注点来自业绩披露要点:翔宇医疗2025年归属净利润同比下降23.55%。公司公告汇总河南翔宇医疗设备股份有限公司发布2025年度业绩快报,营业总收入为76,774.74万元,同比增长3.26%;归属于母公司所有者的净利润为7,869.90万元,同比下降23.55%;扣除非经常性损益的净利润为5,895.43万元,同比下降34.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2614526678","title":"翔宇医疗(688626)披露2025年度业绩快报公告,2月27日股价上涨2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614526678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614526678?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:44","pubTimestamp":1772203454,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,翔宇医疗报收于67.37元,较前一交易日上涨2.7%,最新总市值为107.79亿元。近日,河南翔宇医疗设备股份有限公司发布2025年度业绩快报,营业总收入为76,774.74万元,同比增长3.26%;归属于母公司所有者的净利润为7,869.90万元,同比下降23.55%;扣除非经常性损益的净利润为5,895.43万元,同比下降34.48%。报告期末总资产为326,863.19万元,同比增长11.64%;归属于母公司的所有者权益为207,010.39万元,同比增长1.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2603985126","title":"翔宇医疗:“面向难治性抑郁症的闭环经颅刺激系统”项目入围2025年人工智能医疗器械创新任务揭榜挂帅名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2603985126","media":"证券日报 ","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603985126?lang=zh_cn&edition=full","pubTime":"2026-01-15 21:37","pubTimestamp":1768484220,"startTime":"0","endTime":"0","summary":"证券日报网讯 1月15日,翔宇医疗在互动平台回答投资者提问时表示,近日,公司牵头申报的“面向难治性抑郁症的闭环经颅刺激系统”项目成功入围2025年人工智能医疗器械创新任务揭榜挂帅名单。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180317.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","09996","159883","BK1222","BK1583","BK1574","161631","688626","09997","BK1100"],"gpt_icon":0},{"id":"2603862337","title":"【机构调研记录】中邮基金调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603862337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603862337?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435279,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及1月14日披露的机构调研信息,中邮基金近期对1家上市公司进行了调研,相关名单如下:1)翔宇医疗 调研纪要:脑机接口产品覆盖吞咽、运动、认知等康复场景,有望于2026年实现快速商业化落地。中邮基金成立于2006年,截至目前,资产管理规模759.2亿元,排名73/212;资产管理规模719.8亿元,排名59/212;管理公募基金数109只,排名72/212;旗下公募基金经理24人,排名61/212。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500005047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2603362358","title":"【私募调研记录】瑞民投资调研新开普、翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603362358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603362358?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435272,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息,知名私募瑞民投资近期对2家上市公司进行了调研,相关名单如下:1)新开普 调研纪要:公司与阿里云、支付宝等阿里系平台保持深度协同,阿里作为战略股东提供技术、算力、生态等多维度战略赋能,并于2025年5月29日在河南省人工智能大会上,与阿里云就新开普校园大模型项目完成战略签约。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0170","BK0133","300248","BK0231","BK0077","BK0091","BK0129","BK0251","BK0093","BK0023"],"gpt_icon":0},{"id":"2603623375","title":"【私募调研记录】景泰利丰调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603623375?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435269,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息,知名私募景泰利丰近期对1家上市公司进行了调研,相关名单如下:1)翔宇医疗 调研纪要:脑机接口产品覆盖吞咽、运动、认知等康复场景,有望于2026年实现快速商业化落地。近20个省市已出台脑机接口相关收费标准,推动临床普及。截止2019年,景泰已为招商银行总行、民生银行、平安保险集团等多家专业金融机构提供股票委外服务超过5年。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","00494","688626"],"gpt_icon":0},{"id":"2603324623","title":"【私募调研记录】明世伙伴基金调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603324623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603324623?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435268,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息,知名私募明世伙伴基金近期对1家上市公司进行了调研,相关名单如下:1)翔宇医疗 调研纪要:脑机接口产品覆盖吞咽、运动、认知等康复场景,有望于2026年实现快速商业化落地。近20个省市已出台脑机接口相关收费标准,推动临床普及。明世伙伴基金是一家由专业人士发起,并以资深的专业投研团队为核心而创建的私募证券类基金公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2603623326","title":"【私募调研记录】正圆投资调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603623326?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:00","pubTimestamp":1768435256,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息,知名私募正圆投资近期对1家上市公司进行了调研,相关名单如下:1)翔宇医疗 调研纪要:脑机接口产品覆盖吞咽、运动、认知等康复场景,有望于2026年实现快速商业化落地。近20个省市已出台脑机接口相关收费标准,推动临床普及。机构简介:深圳正圆投资2015年成立于深圳前海自贸区,并于当年获得私募证券投资基金牌照。正圆拥有专业的投研团队,丰富的投资经验,完善的风险管理制度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2603643704","title":"股市必读:翔宇医疗(688626)1月14日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2603643704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603643704?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:00","pubTimestamp":1768410037,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘,翔宇医疗报收于81.5元,下跌6.04%,换手率6.13%,成交量9.81万手,成交额8.14亿元。来自公司公告汇总:股东安阳启旭拟减持不超过480万股,占总股本不超过3%,减持原因为自身资金需求,减持期间为2026年2月4日至5月3日。公司公告汇总翔宇医疗关于股东减持股份计划公告河南翔宇医疗设备股份有限公司股东安阳启旭贸易咨询服务中心持有公司股份8,602,320股,占总股本的5.38%,股份来源于首次公开发行前取得。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500000799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2603685154","title":"翔宇医疗最新公告:股东安阳启旭拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603685154","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603685154?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:40","pubTimestamp":1768304419,"startTime":"0","endTime":"0","summary":"翔宇医疗(688626.SH)公告称,股东安阳启旭贸易咨询服务中心(有限合伙)计划减持不超过480万股,占公司总股本的3%,减持方式为集中竞价和大宗交易,其中集中竞价减持不超过160万股,大宗交易减持不超过320万股。减持原因为自身资金需求,减持期间为2026年2月4日至2026年5月3日。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300036683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2602335815","title":"每周股票复盘:翔宇医疗(688626)因股价涨幅登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2602335815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602335815?lang=zh_cn&edition=full","pubTime":"2026-01-11 01:25","pubTimestamp":1768065909,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,翔宇医疗报收于79.09元,较上周的60.5元上涨30.73%。本周,翔宇医疗1月7日盘中最高价报95.0元,股价触及近一年最高点。本周关注点来自交易信息汇总:翔宇医疗因日收盘价涨幅达15%及三日累计偏离值达30%登龙虎榜。来自公司公告汇总:翔宇医疗2025年前三季度归母净利润同比下降40.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2601803014","title":"马斯克放话“将量产”引爆脑机接口行情,多家上市公司紧急提示风险,是题材炒作还是新风口?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803014","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601803014?lang=zh_cn&edition=full","pubTime":"2026-01-07 20:56","pubTimestamp":1767790578,"startTime":"0","endTime":"0","summary":"自1月5日开盘以来,脑机接口概念股持续活跃。1月7日,脑机接口概念股再度冲高,美好医疗、创新医疗、南京熊猫等走出3连板,三博脑科涨超10%。但同时,板块内部出现分化,前期走强的爱朋医疗、翔宇医疗出现回调。消息面上,马斯克近日表示,其脑机接口公司“神经连接(Neuralink)”将于2026年开始对脑机接口设备进行“大规模生产”,并转向“更加精简和几乎完全自动化的外科手术流程”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601073611709597.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601073611709597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2290526834.HKD","LU2250418816.HKD","002173","LU0056508442.USD","LU2357305700.SGD","LU2471134796.USD","LU0345769631.USD","LU0820561909.HKD","LU1551013342.USD","LU2456880835.USD","LU2213496289.HKD","LU0316494557.USD","IE00BJLML261.HKD","LU1861220033.SGD","688626","LU2756315664.SGD","LU0943347566.SGD","IE00BSNM7G36.USD","IE00B1BXHZ80.USD","LU1914381329.SGD","IE00B19Z9505.USD","IE00BWXC8680.SGD","LU0689472784.USD","LU2750360641.GBP","LU1232071149.USD","LU0320765059.SGD","LU1861558580.USD","BK4550","BK4581","LU0466842654.USD","LU0234572021.USD","BK4527","LU0708995401.HKD","LU2236285917.USD","SG9999015945.SGD","BK4612","LU0672654240.SGD","BK4551","LU0820562030.AUD","LU0097036916.USD","LU2417539215.USD","LU1066051225.USD","LU1674673691.USD","LU0082616367.USD","BK4534","LU0348723411.USD","LU2471134952.CNY","LU2462157665.USD","LU2756315318.SGD","SG9999015952.SGD","LU0109391861.USD","LU1551013425.SGD","LU1145028129.USD","LU2063271972.USD","LU2896262040.SGD","LU1861559042.SGD","BK4511","UFO","LU2750360997.AUD","LU1629891620.HKD","LU2326559502.SGD","LU0053666078.USD","BK4604","LU1066051498.USD","LU2108987350.USD","LU1778281490.HKD","LU2023250330.USD","LU1861215975.USD","BK4533","LU1066053197.SGD","LU0823411888.USD","BK4592","LU2471134879.HKD","LU2403377893.USD","LU0210536198.USD","LU2360107168.USD","LU1720051108.HKD","LU0198837287.USD","LU1366192091.USD","LU0823414478.USD","SG9999015986.USD","SG9999015978.USD","LU0820561818.USD","LU0964807845.USD","LU1429558221.USD","BK4099","LU2249611893.SGD","LU2360106780.USD","IE0034235303.USD","IE00BK4W5L77.USD","LU0234570918.USD","LU1066051811.HKD","LU1267930730.SGD","TSYW.SI","LU0345770993.USD","LU0323591593.USD","BK4598","LU2602419157.SGD","LU1839511570.USD","LU1852331112.SGD","LU2471134523.USD","BK4543","LU0077335932.USD","LU2420271590.USD","BK4585","BK4555","IE00BK4W5M84.HKD","IE00B19Z8X17.USD","LU1720051017.SGD","LU1435385759.SGD","LU1674673428.USD","LU0345769128.USD","LU1548497426.USD","IE00B19Z8W00.USD","BK4548","LU0719512351.SGD","BK4516","BK4574","LU2087621335.USD","LU0345770308.USD","BK4588","IE00B1XK9C88.USD"],"gpt_icon":0},{"id":"2601810334","title":"股市必读:翔宇医疗(688626)登1月6日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2601810334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601810334?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:37","pubTimestamp":1767728230,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,翔宇医疗报收于87.12元,上涨20.0%,已连续涨停2天,换手率5.4%,成交量8.63万手,成交额7.42亿元。来自龙虎榜上榜:翔宇医疗因单日涨幅达15%且三日累计涨幅偏离值达30%,登龙虎榜。龙虎榜上榜沪深交易所2026年1月6日公布的交易公开信息显示,翔宇医疗因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券,有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2601993748","title":"2连板翔宇医疗:目前主要聚焦非侵入式脑机接口技术截至2025年末尚未实现规模化销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601993748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601993748?lang=zh_cn&edition=full","pubTime":"2026-01-06 19:01","pubTimestamp":1767697288,"startTime":"0","endTime":"0","summary":"公司目前主要聚焦非侵入式脑机接口技术,覆盖作业疗法、运动疗法、认知言语、吞咽等康复全场景布局,与当前国际上的侵入式脑机接口技术路线存在差异。公司在脑机接口方面的投入,目前在技术、产品、渠道市场等方面形成一定的布局,但招投标和销售等具有滞后性,截至2025年末,相关产品尚未实现规模化销售,营收占比较小。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600035600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2601546958","title":"异动快报:翔宇医疗(688626)1月6日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601546958","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601546958?lang=zh_cn&edition=full","pubTime":"2026-01-06 09:48","pubTimestamp":1767664099,"startTime":"0","endTime":"0","summary":"证券之星1月6日盘中消息,9点34分翔宇医疗触及涨停板。其所属行业医疗器械目前上涨。领涨股为博拓生物。该股为脑科学,医疗器械,养老产业概念热股,当日脑科学概念上涨6.53%,医疗器械概念上涨1.66%,养老产业概念上涨0.76%。1月5日的资金流向数据方面,主力资金净流入6959.42万元,占总成交额17.68%,游资资金净流出4895.45万元,占总成交额12.44%,散户资金净流出2063.96万元,占总成交额5.24%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/06/20260106282678.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/06/20260106282678.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260106/31918277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2601910003","title":"马斯克放出“量产时间表”,脑机接口集体涨停,商业化拐点来了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601910003","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601910003?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:50","pubTimestamp":1767599456,"startTime":"0","endTime":"0","summary":"随着马斯克明确给出Neuralink设备2026年启动量产的时间表,脑机接口行业或将迎来从“医疗试验品”向“大众消费品”跨越的关键转折点。市场正对脑机接口在医疗康复、AI互联及人形机器人协同等领域广阔应用前景进行重估。大摩预测,到2045年整个市场规模将跃升至3200亿美元。","market":"sh","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3762545","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"a3b3ff8b53102d7bfda203f04641d58f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3762545","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301363","688626","301293"],"gpt_icon":1},{"id":"2601751180","title":"异动快报:翔宇医疗(688626)1月5日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601751180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601751180?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:36","pubTimestamp":1767576997,"startTime":"0","endTime":"0","summary":"证券之星1月5日盘中消息,9点34分翔宇医疗触及涨停板。其所属行业医疗器械目前下跌。领涨股为明德生物。该股为脑科学,养老产业,医疗器械概念热股,当日脑科学概念上涨6.02%,养老产业概念上涨1.17%,医疗器械概念上涨0.92%。12月31日的资金流向数据方面,主力资金净流入1273.83万元,占总成交额6.85%,游资资金净流入143.76万元,占总成交额0.77%,散户资金净流出1417.59万元,占总成交额7.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500004237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2590053822","title":"翔宇医疗(688626)披露为全资子公司提供担保的进展公告,12月10日股价下跌1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590053822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590053822?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:19","pubTimestamp":1765376380,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘,翔宇医疗报收于48.1元,较前一交易日下跌1.17%,最新总市值为76.96亿元。该股当日开盘48.6元,最高48.85元,最低47.23元,成交额达3737.13万元,换手率为0.49%。公司近日发布公告称,河南翔宇医疗设备股份有限公司为全资子公司河南瑞贝塔医疗科技有限公司向华夏银行股份有限公司郑州分行申请的不超过10,000.00万元贷款提供连带责任担保。截至公告日,公司及控股子公司对外担保总额为10,000.00万元,占公司最近一期经审计净资产的4.91%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2590538649","title":"翔宇医疗:公司不存在逾期担保情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538649","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590538649?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:42","pubTimestamp":1765374120,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月10日晚间,翔宇医疗发布公告称,截至本公告披露日,公司不存在逾期担保情况或涉及诉讼的担保情况。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-10/doc-inhaiqhx0336497.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-10/doc-inhaiqhx0336497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2585517498","title":"翔宇医疗(688626)公司公告取消监事会并修订公司章程,11月24日股价上涨1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585517498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585517498?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:27","pubTimestamp":1763994475,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘,翔宇医疗报收于45.7元,较前一交易日上涨1.87%,最新总市值为73.12亿元。该股当日开盘45.53元,最高46.2元,最低45.0元,成交额达3981.48万元,换手率为0.55%。出席会议的股东共74人,代表表决权股份114,629,702股,占公司总表决权的73.4476%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772304808503,"stockEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0281},{"period":"3month","weight":0.4414},{"period":"6month","weight":0.2205},{"period":"1year","weight":0.8342},{"period":"ytd","weight":0.1136}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0028},{"period":"3month","weight":0.0705},{"period":"6month","weight":0.079},{"period":"1year","weight":0.2287},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南翔宇医疗设备股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9531人(较上一季度增加51.24%)","perCapita":"16787股","listingDate":"2021-03-31","address":"河南省安阳市内黄县帝喾大道中段","registeredCapital":"16000万元","survey":" 河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。公司是同行业率先通过ISO9001和YY/T0287idtISO13485医疗器械质量管理体系、ISO14001环境管理体系、OHSAS18001职业健康安全管理体系和知识产权管理五个体系认证的企业。报告期末,公司已获得专利1,933项,参与起草或参与评定36个国家行业标准,获得省级科技成果248项。","listedPrice":28.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翔宇医疗,688626,翔宇医疗股票,翔宇医疗股票老虎,翔宇医疗股票老虎国际,翔宇医疗行情,翔宇医疗股票行情,翔宇医疗股价,翔宇医疗股市,翔宇医疗股票价格,翔宇医疗股票交易,翔宇医疗股票购买,翔宇医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}